US FDA grants approval to Granules India for its generic Amphetamine Mixed Salts
Amphetamine Mixed Salts IR tablets are prescribed for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy
Hyderabad: Granules India announced today that it has received approval from the US Food & Drug Administration (US FDA) on Abbreviated New Drug Application (ANDA) filed for Amphetamine Mixed Immediate Release Tablets. The regulatory body has granted approval to the Amphetamine Mixed Salts IR tablets in the capacity of 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg and 30mg. It is a bioequivalent to the reference listed drug product (RLD) Adderall, a registered trademark of Teva Women
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!